<DOC>
	<DOCNO>NCT02282085</DOCNO>
	<brief_summary>This study compare aripiprazole once-monthly injection standard care oral antipsychotic medication non-adherent outpatient schizophrenia see treatment help people take medicine regularly positive outcome . It hypothesize non-adherent schizophrenia outpatient receive aripiprazole once-monthly likely respond lower symptom severity 3 month treatment receive standard care oral antipsychotic .</brief_summary>
	<brief_title>Treatment Study Comparing Aripiprazole Once Monthly With Standard Care Medication Outpatients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Are able provide write informed consent . If Institutional Review Board ( IRB ) require consent legally acceptable representative addition subject , required consent must obtain prior initiation protocolrequired procedure . Are 18 60 year age , inclusive , time inform consent Has current diagnosis schizophrenia , define DSMV criterion history illness least 6 month prior screen reliable source ( e.g. , health care provider , family member , medical record ) . Have prescribe single oral antipsychotic medication least 3 month prior screen . Are able understand nature study follow protocol requirement , include prescribed dosage regimen , tablet ingestion , intramuscular ( IM ) monthly injection , discontinuation prohibit concomitant medication , read understand write word order complete subjectreported outcome measure , reliably rat assessment scale . Are male female subject surgically sterile ( i.e. , undergone orchiectomy hysterectomy , respectively ; female subject postmenopausal least 12 consecutive month ; male female subject agree remain abstinent practice double barrier form birth control study screen 30 day ( female ) 90 day ( male ) last dose study drug SOC oral antipsychotic 150 day females 180 day male aripiprazole monthly . If employing birth control , two follow precaution must use : vasectomy , tubal ligation , vaginal diaphragm , intrauterine device , birth control pill , birth control implant , birth control monthly injection , condom , sponge spermicide . Has current DSMV diagnosis schizophrenia , include schizophreniform disorder , schizoaffective disorder , major depressive disorder , bipolar disorder , delirium , dementia , amnestic cognitive disorder . Also exclude subject borderline , paranoid , histrionic , schizotypal , schizoid , antisocial personality disorder . Has psychiatric hospitalization within 30 day prior screen . Has receive depot antipsychotic within 6 month prior screen . Is consider resistant refractory antipsychotic treatment history ( fail two prior antipsychotic medication study ) response clozapine . Is take two antipsychotic . Has significant risk violent behavior significant risk commit suicide base history investigator 's discretion . Has history seizures medical condition would expose subject undue risk interfere study assessment . Is involuntarily incarcerate incarcerate past 6 month reason . Has undergone electroconvulsive therapy 2 year prior enrollment study . Has use investigational agent participate clinical study aripiprazole monthly antipsychotic monthly preparation within 30 day screen . Has medical condition might preclude safe completion study ( e.g. , agranulocytosis , severe unstable heart disease , AIDS , endstage renal disease ) . Is take CYP3A4 inducer ( e.g. , carbamazepine ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Medication Non-Adherence</keyword>
	<keyword>Antipsychotic</keyword>
</DOC>